Up to 47 million Americans may have “preclinical” Alzheimer’s disease, study estimatesDecember 13, 2017Alzheimer's & CognitionNeurologyGeriatrics
Retinal changes may reflect brain changes in preclinical Alzheimer’sDecember 4, 2017Alzheimer's & CognitionGeriatricsNeurology
Walking has beneficial cognitive effects in amyloid-positive older adultsDecember 3, 2017Alzheimer's & CognitionGeriatricsNeurology
Intepirdine flops in phase 3 study of mild to moderate Alzheimer’s patientsNovember 28, 2017Alzheimer's & CognitionNeurologyGeriatrics
Development of a sigma 1 receptor agonist for Alzheimer’s proceeds based on 2-year phase 2 dataNovember 21, 2017Alzheimer's & CognitionNeurology
Long-term cholinesterase inhibition may slow cognitive decline – and moreNovember 15, 2017Alzheimer's & CognitionNeurologyGeriatrics
Pimavanserin found modestly effective in phase 2 Alzheimer’s psychosis studyNovember 14, 2017Alzheimer's & CognitionGeriatricsNeurology
Amyloid imaging changed management for 80% of patients with uncertain dementia diagnosisNovember 9, 2017Alzheimer's & CognitionNeurologyGeriatrics
New BACE1 study launches in the shadow of verubecestat’s demiseNovember 4, 2017Alzheimer's & CognitionNeurologyGeriatrics
Aducanumab continues to rack up positive numbers in phase 1b open-label extensionNovember 3, 2017Alzheimer's & CognitionGeriatricsNeurology
In Lewy body disease, CSF may reveal dementia riskNovember 3, 2017Alzheimer's & CognitionMovement Disorders
Analysis of failed Alzheimer’s trials gives two antiamyloid antibodies new momentumNovember 2, 2017Alzheimer's & CognitionGeriatricsNeurology
Lumateperone shows broad phase 3 potential for psychiatric disordersOctober 29, 2017Schizophrenia & Other Psychotic DisordersBipolar DisorderAlzheimer's & Cognition
VIDEO: Alzheimer’s blood test expected soonOctober 19, 2017Alzheimer's & CognitionNeurologyGeriatrics
APOE affects tau pathology independent of amyloid-betaOctober 4, 2017Alzheimer's & CognitionNeurology
